Advanced or Metastatic Solid Tumors

Oncology·MeSH: Breast Neoplasms

30 drugs in development·22 companies·11 clinical trials

Drug Pipeline by Phase

Phase 3(8)

Drug	Company
Lazertinib	ENANTA PHARMACEUTICALS INC (ENTA)
Naporafenib	Erasca, Inc. (ERAS)
surzebiclimab	BeOne Medicines Ltd. (ONC)
tak-188	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tak-188	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-981	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-981	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Trametinib	Erasca, Inc. (ERAS)

Phase 2(5)

Drug	Company
Amivantamab	ENANTA PHARMACEUTICALS INC (ENTA)
Direct Oral Anticoagulant	Structure Therapeutics Inc. (GPCR)
iph4502	Innate Pharma S.A. (IPHA)
pc14586	PMV Pharmaceuticals, Inc. (PMVP)
Pemetrexed	Structure Therapeutics Inc. (GPCR)

Phase 1(12)

Drug	Company
amg 410	AMGEN INC (AMGN)
BGB-53038	ENANTA PHARMACEUTICALS INC (ENTA)
BGB-B455	Merus N.V. (MRUS)
CB-708 (ATG-037)	Calithera Biosciences, Inc. (CALA)
day301	Day One Biopharmaceuticals, Inc. (DAWN)
etigilimab	OncoMed Pharmaceuticals Inc (OMED)
IDE-161	IDEAYA Biosciences, Inc. (IDYA)
MRG007	ArriVent BioPharma, Inc. (AVBP)
ngm438	NGM BIOPHARMACEUTICALS INC (NGM)
ngm831	NGM BIOPHARMACEUTICALS INC (NGM)
TAK-188	Merus N.V. (MRUS)
XB010	EXELIXIS, INC. (EXEL)

Preclinical(1)

Drug	Company
iv rhdnase i	Xenetic Biosciences, Inc. (XBIO)

Phase 1/Phase 2(4)

Drug	Company
dcc-3116	Deciphera Pharmaceuticals, Inc. (DCPH)
iph4502	Innate Pharma SA (IPHYF)
nc762	NextCure, Inc. (NXTC)
wtx-330	Werewolf Therapeutics, Inc. (HOWL)

BioSniper tracks 30 drugs in development for Advanced or Metastatic Solid Tumors across 22 companies.

There are 11 clinical trials targeting Advanced or Metastatic Solid Tumors tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.